Prevention of foscarnet nephrotoxicity.
Deray
G
G
Katlama
C
C
Dohin
E
E
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D015828:Eye Infections, Viral / Q000188:drug therapy*; D005260:Female; D005440:Fluid Therapy; D017245:Foscarnet; D006801:Humans; D007674:Kidney Diseases / Q000517:prevention & control*; D008297:Male; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D012965:Sodium Chloride / Q000008:administration & dosage
D000998:Antiviral Agents; D017245:Foscarnet; D012965:Sodium Chloride; D010746:Phosphonoacetic Acid